The results showed that metformin administration did not change serum visfatin levels in the patients with PCOS, with a corresponding SMD of -0.04 (95% CI: -1.55 to 1.46, P>0.05) (Fig 8). Here, NAMPT is linked to polycystic ovary syndrome.